title: NICE recommends dropping two drugs from Cancer Drugs Fund.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000970:Antineoplastic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D004739:England; D000068338:Everolimus / Q000191:economics*; D005569:Formularies as Topic; D006801:Humans; D010880:Piperidines; D011720:Pyrazoles / Q000191:economics*; D011743:Pyrimidines / Q000191:economics*; D013222:State Medicine / Q000191:economics
chemical_list: D000970:Antineoplastic Agents; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000068338:Everolimus; D000225:Adenine